Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
A SPAC I Acquisition Unit | ASCAU | Jul 26, 2024 | 2.96 | 0.00 |
A SPAC II Acquisition | ASCB | Jul 26, 2024 | 11.25 | 0.00 |
A-Mark Precious Metals | AMRK | Jul 26, 2024 | 38.40 | +4.86 |
a.k.a Brands | AKA | Jul 26, 2024 | 16.39 | +4.93 |
A.O Smith | AOS | Jul 26, 2024 | 84.50 | +2.82 |
A10 Networks | ATEN | Jul 26, 2024 | 14.25 | +0.99 |
A2Z Smart Technologies | AZ | Jul 26, 2024 | 0.78 | +5.44 |
AAA - A Rated Corporate Bond Ishares | QLTA | Jul 26, 2024 | 47.44 | +0.47 |
Aadi Bioscience | AADI | Jul 26, 2024 | 1.58 | -1.86 |
AAON | AAON | Jul 26, 2024 | 87.59 | +2.55 |
AAR | AIR | Jul 26, 2024 | 66.62 | +0.51 |
Abacus Life | ABL | Jul 26, 2024 | 9.93 | -1.39 |
Abbott Laboratories | ABT | Jul 26, 2024 | 105.24 | -0.68 |
AbbVie | ABBV | Jul 26, 2024 | 185.16 | +1.64 |
AbCellera Biologics | ABCL | Jul 26, 2024 | 3.26 | +5.16 |
Abeona Therapeutics | ABEO | Jul 26, 2024 | 5.10 | +1.39 |
Abercrombie & Fitch | ANF | Jul 26, 2024 | 152.59 | +0.70 |
Aberdeen Asia-Pacificome Fund | FAX | Jul 26, 2024 | 2.76 | 0.00 |
Aberdeen Australia Equity Fund | IAF | Jul 26, 2024 | 4.37 | +1.04 |
Aberdeen Emerging Markets Fund | AEF | Jul 26, 2024 | 5.17 | 0.00 |
Aberdeen Global Fund | FCO | Jul 26, 2024 | 5.81 | +0.87 |
Aberdeen Global Infrastructure | ASGI | Jul 26, 2024 | 18.31 | -0.87 |
Aberdeen Income Credit Strategies Fund | ACP | Jul 26, 2024 | 6.48 | 0.00 |
Aberdeen Income Credit Strategies Pref | ACP-A | Jul 26, 2024 | 24.10 | 0.00 |
Aberdeen Japan Equity Fund | JEQ | Jul 26, 2024 | 5.88 | +0.68 |
Abits Group | ABTS | Jul 26, 2024 | 0.55 | +10.60 |
Abivax SA - American Depositary Shares | ABVX | Jul 26, 2024 | 11.86 | +0.34 |
Able View Global | ABLV | Jul 26, 2024 | 1.18 | -2.48 |
ABM Industries | ABM | Jul 26, 2024 | 55.08 | +0.86 |
Above Food Ingredients | ABVE | Jul 26, 2024 | 1.46 | 0.00 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.